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Summary 
Although much has been learned about the molecular  basis of immunoglobulin M (IgM) rheumatoid 
factors (KFs) in healthy individuals and in patients with mixed cryoglobulinemia and rheumatoid 
arthritis,  little is known about  the genetic origins of the potentially pathogenic IgG RFs in 
the inflamed rheumatoid synovia  of patients. Recently, we generated from unmanipulated synovium 
B cells several  hybridomas that secreted self-associating IgG KFs. To delineate the genetic origins 
of such potentially pathogenic RFs, we adapted the anchored polymerase chain reaction to rapidly 
clone and characterize the expressed  Ig V genes for the L1 and the D1 IgG RFs. Then, we identified 
the germline counterparts  of the expressed L1 IgG KF V genes. The results showed that the 
L1 heavy chain was encoded by a Vh gene that is expressed preferentially during early ontogenic 
development, and that is probably located within 240 kb upstream of the Jh locus. The overlap 
between this KF Vh gene and the restricted fetal antibody repertoire is reminiscent of the natural 
antibody-associated Vh genes, and suggests that at least part of the "potential pathogenic" IgG 
RFs in rheumatoid synovium may derive from the "physiological" natural antibody repertoire 
in a normal immune system. Indeed, the corresponding germline Vh gene for L1 encodes the 
heavy chain of an IgM KF found in a 19-wk-old fetal spleen. Furthermore,  the comparisons 
of the expressed ILF V genes and their germline counterparts reveal that the L1 heavy and light 
chain variable regions had, respectively, 16 and 7 somatic mutations,  which resulted in eight 
and four amino acid changes. Strikingly, all eight mutations in the complementarity  determining 
regions of the V gene-encoded  regions were replacement changes, while only 6 of 11 mutations 
in the framework regions caused amino acid changes. Combined with Ll's high binding affinity 
toward the Fc fragment, these results suggest strongly that the L1 IgG KF must have been driven 
by the Fc antigen. 
heumatoid arthritis  (RA)  z is an extravascular immune 
complex disease of unknown etiology (1). The diag- 
nostic autoantibody in most RA patients is termed rheuma- 
toid factor (RF); this antibody bind to the Fc region of IgG 
1 E.  W.  Lu  made  an  equal  contribution  to  this  work  and  thus  is 
considered  as a co-first author. 
2 Abbreviations used in  this paper: APCR,  anchored  polymerase  chain 
reaction; FK, framework region; RA, rheumatoid arthritis; RF, rheumatoid 
factor. 
molecules (2). Studies have shown that synovial fluid from 
the inflamed joints in RA patients contains abundant  ag- 
gregates of Ig, and depressed levels of complement compo- 
nents. The aggregates consist of mainly IgG and KFs, which 
are synthesized and deposited in situ (3, 4). These findings 
suggest that KFs may contribute to immune c9mplex for- 
mation, complement consumption, and chronic tissue damage 
in the rheumatoid synovium (5). 
However, similar to other "natural" autoantihodies, RFs 
are also found routinely in apparently healthy individuals; 
such RFs generally are polyspecific,  low affinity, and belong 
to the IgM isotype (6-10). Structural and molecular analyses 
of such IgM KFs from CD5 + B cells of normal subjects, 
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have revealed that they are encoded by a restricted set of Ig 
variable  (V) region genes with no or a few somatic muta- 
tions, i.e., up to eight amino acid substitutions per 96-98 
residues in a light (L) or heavy (H) chain V region (11-15). 
In contrast to the natural RFs in normal individuals, the 
RFs in RA patients, particularly those found in the inflamed 
joints, contain both IgM and IgG isotypes. Also, in addition 
to the low affinity and polyspecific RFs, RA patients have 
high affinity and monospecific RFs (2, 16, 17). Thus, to un- 
derstand the role of RFs in the pathogenesis of R.A, it is im- 
portant to study the latter RFs, particularly the IgG RFs 
found mainly in rheumatoid synovium. What are the genetic 
bases of IgG RFs? Do they use V genes similar to those used 
by IgM RFs in normals and patients with mixed cryoglob- 
ulinemia? What are the inducing and/or sustaining factors 
for the disease-specific IgG RFs in patients? Are these anti- 
bodies driven nonspecifically by mitogens or specifically by 
IgG and/or unknown crossreacting antigens? 
To delineate the underlying mechanisms for IgG RF syn- 
thesis in RA patients, we now report the molecular charac- 
terization of the L1 IgG3' and the D1 IgGk RFs (18). These 
RFs bind specifically to the human Ig Fc fragment with high 
affinity, as indicated by their estimated dissociation constants 
(Ka) of 4.1  x  and 5.2  x  10-7 M, and, at 500 #g/ml, self- 
associate into homodimers. Thus,  these IgG RFs have the 
potential to form large aggregates which are then deposited 
in  extravascular  sites,  and  thus  trigger  the  inflammatory 
pathways leading to chronic tissue damage. In addition to 
defining the RF H and L chain cDNA (designated HumhalL1, 
HumlalL1, Humha3dl, and Humka3dl, respectively), we also 
isolated the L1-RF-corresponding germline V genes (desig- 
nated HumhvlL1 and HumlvlL1, respectively). Interestingly, 
the hvlL1 germline gene is almost identical to 20P3, a cDNA 
found in a fetal liver, and to the V35  gene located within 
240 kb upstream of theJh locus (19-21). The data are reminis- 
cent of the natural antibody-associated Vh genes  (15), and 
suggest that at least part of the "potential pathogenic" IgG 
RFs in rheumatoid synovium may derive from the "physio- 
logical" natural antibody repertoire  in  a  normal immune 
system. Indeed, hvlL1 is 99%  homologous to the Vh se- 
quence of the ML3 IgM R.F found very recently in a 19-wk- 
old fetal spleen (22).  In addition, the patterns of mutations 
were not random and suggested that the L1 IgG RF was 
highly likely to be driven by the antigen Fc fragment. Com- 
bined, these data implied that some IgG RFs in RA patients 
may come from natural IgM RFs of a normal immune system, 
possibly be escaping from the normal regulation during a 
transient breakdown of the immune system and/or overloading 
of the system with immune complexes. 
Materials and Methods 
DNA and RNA Isolation  from the L1 and the 191 IgG RF-secreting 
Hybridomas andRA Patient  ML.  The L1 and D1 hybridomas  were 
derived, respectively, from synovial cells of the seropositive RA 
patients ML and AD, who satisfied  the 1987 American  Rheumatism 
Association (American College of Rheumatology) criteria for RA 
(18, 23). The mAbs react strongly with the Fc fragment of human 
IgG, but not other six unrelated antigens, including human col- 
hgen VI, BSA, chicken  OVA, KLH, tetanus toxoid, and calf  thymus 
single-stranded DNA (18). The mRNA was isolated from the hy- 
bridoma with the Extract a Gene Kit (Oncor, Gaithersburg, MD) 
according to the manufacturer's  instructions. Genomic  DNAs were 
prepared from both hybridoma and PBL of patient ML. 
Rapid Cloning of the RF 9" H, A and ~r L chain V Regions (Vh, 
VA, and VK)cDNA by Anchored  PCR (APCR)(24, 25).  Recently, 
a synovium-derived  RF was found to use a novel VX 8 gene (26). 
To avoid  any possible  problems with unknown V gene families  and 
to clone rapidly  the expressed  V genes in the hybridomas,  we adapted 
the reported APCR method (25). Briefly, the first-strand cDNA 
was synthesized from the hybridoma mRNA with an oligo(dT) 
primer  and murine leukemia virus reverse transcriptase, and a 
poly(dG) tail was added to the 3' end of the cDNA with terminal 
deoxynucleotidyl transferase. Thereafter, the  tailed cDNA was 
amplified with two 5' universal primers and a 3' primer for either 
the 3~ H chain, the X L chain, or the g L chain. The 5' primers 
were the  AN  (anchor) primer  (5'-CACGT-CGACC-TAGGC- 
GGCCG-CGG)  and  the  ANpolyC  primer  (5'-AN-CCCCC- 
CCCCC-CCCC, where AN stand for the AN primer sequence) 
(25); they were used at the 9:1 ratio. The 3' primers for the y, 
the ~,, and the K  chain, respectively,  were the GCc primer (where 
G, C, and c stand for the gamma chain constant region, and the 
complementary strand; 5'-GTAGT-CCTTG-ACCAG-GCA,  com- 
plementary  to nucleotides  474-457 in Fig. 1), the LCc primer (where 
L stands for lambda chain; 5'-AGTGT-GGCC'IZl'GTTG-GCTTG, 
complementary to nucleotides 410-391 in Fig. 2), and the KCc 
primer  (where K  stands for kappa chain; 5'-GAAGA-TGAAG- 
ACAGA-TGGTG-C,  complementary  to nucleotides  354-334 in Fig. 
6). These three primers were designed to prime all %  ~,, and K 
chains. Either a BamHI or a PstI site was added to the 5' end of 
these three primers. 
To the tailed cDNA and the appropriate primers, all four deox- 
ynucleotide triphosphates and Taq polymerase  were added, and the 
mixture was amplified  for 30 cycles. Each cycle consisted of a 45-s 
denaturation at 94~  a 45-s primer annealing  at 46~  and a 1-min 
(except for a 7-min in the last cycle)  extension  at 72~  The amplified 
products were visualized by running 10% (10/~1) of the reaction 
on a 1% agarose gel. In some cases, to improve the quantity and 
quality of the desired  3' and ~ chain gene products, the tailed  cDNA 
was first amplified, respectively,  with two additional downstream 
primers, GClc and KClc (complementary to sequences marked in 
Figs. 5 and 6), and the amplified  product of the expected size was 
enriched from the agarose gel and re-amplified  with GCc and KCc. 
PCR-based Cloning of  the Rearranged Vh and VA Genes(designated 
HumhalL1 and HumlalL1) and Their Germline Counterparts (Desig- 
nated HumhvlL1 and HumlvIL1).  To amplify the Ll-rearranged 
Vh gene, 1 #g of  hybridoma DNA was mixed with 100 pmol each 
of the appropriate primers in a buffer containing 1.5 mM Mg  z+ . 
The upstream primer halLIUls (where U and s denote upstream 
and sense strand, respectively) correspond to a sequence in the 5' 
untranslated region, and the downstream primer Jh3c was com- 
plementary to a portion of Jh3 (marked in Fig. 1). For isolating 
the germline gene counterpart, germline DNA from the PBL of 
patient ML was amplified  with the upstream halL1Uls primer and 
a new downstream primer, V35D1c (complementary to sequence 
from positions 336 to 317 in the V35 gene, marked in Fig. 3) (21). 
In all cases, the restriction endonuclease  recognition sequences for 
SalI and PstI were present at the 5' ends of  the upstream and down- 
stream primers, respectively.  For amplification,  the DNA was mixed 
with the indicated primers, all four deoxynucleotide  triphosphates, 
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Each cycle consisted of I  min melting at 94~  1 min annealing 
at 55~  and 1.5 min (7 min during the last cycle) elongation at 
72~  After amplification,  the PCR products were analyzed by 
gel electrophoresis. 
Similarly,  the rearranged L1 V)~ gene and its germline counter- 
part were amplified with appropriate primers. The rearranged L1 
V), gene was amplified with the 5' primer (lalL1U2s, corresponds 
to  a  stretch  in  the  5'  untranslated  region)  and  the  3'  primer 
(lalL1C3c, complementary to the 3' end of CDR3  and the first 
three bases of the fourth framework region (FR4) (Fig. 2). To iso- 
late the lalL1 gem'dine gene counterpart, lalLIU2s was paired with 
a series of downstream primers, corresponding to various stretches 
in the 3' end of the V gene-encoding region of the lalL1 sequence 
and in the immediate 3' flank of the reported Humlv117 VM gene 
(27). The results showed that two downstream primers yielded clean 
bands of the expected sizes. They were lalL1C3cl and lv117D1c, 
complementary to regions marked in Fig. 4. 
Cloning and Sequencing of the Amplified DNA.  The amplified 
DNA was digested with the appropriate enzymes, and was cloned 
into M13mp8 (28). For the H and the L chain cDNAs, the recom- 
binant phages were screened with the GC3s and the LC4s primers, 
respectively (marked in Figs. I and 2). The hybridization was done 
in 6x  SSPE (20x  SSPE is 3.6 M  NaC1, 200 mM sodium phos- 
phate, 20 mM EDTA, pH 7.4) containing 5 x  Denhart's solution 
(lx  is 0.02%  Ficoll,  0.02% polyvinylpyrrolidone, 0.02% BSA), 
at 55~  Hybridized filters were washed with 6 x  SSPE four times 
at room temperature for 15 min each and the positive clones were 
visualized by autoradiography. Single-stranded DNA was prepared 
from the chosen M13 clones, and the inserted DNA was sequenced 
by the method of Sanger (28a) using the universal M13 sequencing 
primer. Because of possible base infidelity generated during PCR 
amplification, each of the presented sequences  represents either at 
least two completely identical sequences  from the amplified DNA 
or a consensus sequence from at least three 99% homologous se- 
quences.  The computer programs of the University of Wisconsin 
Genetics Computer Group were used to assemble,  edit, and ana- 
lyze all sequence data (29). 
Results 
Molecular Characterization of the LI Vh and VA cDNA.  The 
amplified DNA from APCR with GCc and LCc were ana- 
lyzed by gel electrophoresis and were found to contain clean 
M  D  W  T  W  R  I  L  F  L  -I0 
halLl  GAGCATCACCCAGCAACCACATCTGTCCTC  TAGAGAATCCCCTGAGAGCTCCGTTCCTCACCATGGACTGGACCTGGAGGATCCTCTTCT  -30 
1  .........  halLiUls  ........  +  .........  + .........  +  .........  +  .........  +  .........  +  .........  +  90 
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halLl  TGGTGGCAGCAGCCACAGGAGCCCAC  TCCCAGGTGCAGCTGGTGCAGTCTGGGGCTGAGGTGAAGAAGCCTGGGGCCTCAGTTAAGGTCT  61 
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halLl 
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CDRI  CDR2 
C  K  G  S  G  Y  T  F  T  A  Y  Q  M  H  W  V  R  Q  A  P  G  Q  G  L  E  W  M  G  W  I  51 
CCTGTAAGGGTTCTGGATACACCTTCACCGCCTACCAAATGCACTGGGTGCGACAGGCcCCTGGACAAGGACTTGAGTGGATGGGATGGA  151 
.........  +  .........  +  .........  + .........  + .........  +  .........  +  .........  +  .........  +  .........  +  270 
CDR2 
N  P  N  S  G  G  T  G  Y  G  Q  K  F  Q  G  R  V  T  L  T  R  D  T  S  I  S  T  A  Y  M  81 
TCAACCCTAACAGTGGTGGCACAGGCTATGGACAGAAGTT  TCAGGGCAGGGTCACCCTGACCAGGGACACGTCCATCAGCACAGCCTACA  241 
.........  +  .........  + .........  +  .........  + .........  + .........  + .........  +  .........  + .........  +  360 
CDR3 
E  L  S  R  L  T  S  D  D  T  A  V  Y  Y  C  A  I  E  Y  F  Y  D  G  S  D  L  K  P  S  D 
TGGAC-CTGAGCAGGCTGACATCTGACGACACGGCCGTGTATTACTGTGCCAT  TGAGTATTT  TTATGATGGCAGTGACTTAAAACCCTCTG 
.........  q~  .........  +  .........  +  .........  +  .........  +  .........  +  .........  + .........  +  .........  + 
.....  AC ......  A-T ....  .  G---TT-- 
-A ....... 
--G---T-.  ---T--- 
iii 
331 
450 
CDR3  <CHI 
V  F  D  I  W  G  Q  G  T  M  V  T  V  S  S  A  S  T  K  G  P  S  V  F  P  L  A  P  S  S  141 
ATGTTTTTGATATcTGGGGCCAAGGGAcAATGGTcACcGTCTCTTCAGCCTccACCAAGGG•ccATcGGTCTTCCCCCTGG•ACCCTCCT  421 
.........  +  .........  +  Jh3c  -+ .........  + .........  +  ....  GC3s  .......  +  .........  +  .........  +  540 
........................................... 
K  S  T  S  G  G  T  A  A  L  G  C  L  V  K  D  Y  158 
halLl  CCAAGAGCACC  TCTGGGGGCACAGCGC-CCC  TGGGC  TGCC  TGGTCAAGGAC  TAC  474 
541  .........  +  .........  + .........  +  .........  +  C-Cc  --+---  593 
~i  ..................................................... 
Figure 1.  The nucleotide and amino acid sequences of the L1 H chain V region, designated HumhalL1  and abbreviated halL1. The expressed V 
gene was rearranged to Jh3 and "),1 genes (33, 34); their reported germline sequences are included for comparison. The nudeotide  sequence in the 
CDR3 of halL1 was compared with all reported Dh gene sequences, and the four most homologous Dh gene segments were identified (30, 31); they 
are given for comparison. The complete nucleotide and amino acid sequences of halL1 are given, while all other sequences are given only at the positions 
where they differ from halL1, in the overlapping regions. The bars and dots denote the identities and the introduced gaps, respectively. The regions 
of four oligomers are underlined and their names are given underneath.  The CDRs are marked. 
833  Olee et al. bands of expected sizes;  the bands also hybridized,  respec- 
tively, with the GC3s and the LC4s primers (located upstream 
of the GCc and the LCc primers, marked in Figs.  1 and 2). 
The results indicated that  the bands contained the Vh and 
V)~ cDNAs, respectively. Accordingly, the amplified DNA 
was cloned into M13 and the recombinants were analyzed. 
The results showed that the L1 IgG RF contained Vhl and 
VM genes, designated HumhalL1  and HumlalL1,  respec- 
tively (Figs.  1 and 2). 
The CDR3 of halL1 contained a stretch of 29 bp that was 
homologous to D21/9  (30),  suggesting  that  the halL1  H 
chain might use this Dh gene with some mutations; alterna- 
tively, this 29-bp stretch might be encoded by three different 
Dh genes (30, 31), as suggested by the similarities between 
each of the three nonoverlapping portions in the same stretch 
and a particular Dh gene (32) (Fig.  1). The introduced gaps 
in either case may represent insertions generated by poorly 
characterized "gene correlation mechanisms," as proposed re- 
cently by Sanz (32). Also, the halL1 H chain used a Jh3 and 
a C3'1  gene (Fig.  1); its Jh region deviated from a Jh3 se- 
quence by one silent change (33), while its C34 region was 
identical to the reported C34 sequence over a 77-bp region 
(34). On the other hand,  the lalL1 L chain used a J)~2 and 
a C)~2 gene (35, 36), instead of the closely related CA3 gene, 
based on a single diagnostic base (G vs. A) at nucleotide po- 
sition 372 (Fig. 2). The expressedJX2 sequence deviated from 
the reported germline sequence by one replacement change 
and two silent changes, while its C)~2 sequence was identical 
to the known Ck2 gene over a 56-bp region. 
Identification and Characterization of the Germline Vh Gene 
for the L1 H  Chain.  Since the upstream  flanking and the 
intron regions of a rearranged Ig V gene do not encode amino 
acid residues, they generally have much fewer somatic muta- 
tions than the coding region. Moreover, among different gene 
members of a V gene family, their upstream flanks and in- 
trons are normally more heterogenous than their coding re- 
gion counterparts.  As such,  the sequences in these regions 
of a rearranged  V  gene often provide better clues for iden- 
tifying its corresponding  germline V  gene. 
Accordingly, we first cloned the rearranged  Vh and V), 
genes from L1. Using halLIUls andJh3c as 5' and 3' primers 
(marked in Fig.  1),  the rearranged  Vh gene was amplified 
and  characterized.  A  comparison  of the  resulting  halL1- 
rearranged  gene sequence with both GenBank and EMBL 
databases revealed that the expressed Vh gene was most similar 
to V35 and 1-1 germline genes; the former is functional, while 
the latter is a pseudogene (21,  37).  Thus,  halL1  might be 
encoded by V35 itself or a Vhl gene highly closely related 
to V35. 
To differentiate between these two possibilities, we com- 
pared the 3' flanks of both V35 and 1-1 with a large number 
of human Vhl genes, and identified a stretch that was iden- 
lalLl 
M  A  S  F  P  L  L  L  T  L  L  T  H  C  A  -5 
GCTTCAGCTGTGGGTAGAGAAGACAGGACTCAGGACAATCTCCAGCATGGCCAGCTTCCCTCTCCTCCTCACCCTCCTCACTCACTGTGC  - 14 
.......  lalLIU2s  + .........  + .........  +  .........  +  .........  + .........  + .........  + .........  +  90 
CDRI 
G  S  W  A  Q  S  V  L  T  Q  P  P  S  A  S  G  T  P  G  Q  R  V  T  I  $  C  S  G  S  N  26 
lalLl  AGGGTCCTGGGCCCAGTCTGTGC  TGACTCAACCACCCTCAGCGTCTGGGACCCCCGGGCAGAGGGTCACCATCTCTTGTTCTGGAAGCAA  77 
91  .........  +---i  .....  + .........  + .........  +  .........  + .........  + .........  +  .........  + .........  +  180 
lalLl 
181 
CDRI  CDR2 
S  N  I  G  G  N  T  V  N  W  Y  Q  Q  L  P  G  T  A  P  K  L  L  I  Y  S  N  N  Q  R  P  56 
CTCCAACAT  CGGAGGTAATAC  TGTAAAC  TGGTACCAGCAGC  TCCCAGGAACGGCCCCCAAACTCCTCATCTATAGTAATAATCAGCGGCC  167 
.........  + .........  +  .........  +  .........  + .........  +  .........  + .........  + .........  + .........  +  270 
CDR2 
SGVPDRFSGSKSGTSASLAISGLQSEDEAA  86 
lalLl  CTCAGGGGTCCCTGACCGATTCTCTGGCTCC~GTCTGGCACCTCAGCCTCCCTGGCCATCAGTGGGCTCCAGTCTGAGGATGAGGCTGC  257 
271  .........  + .........  + .........  + .........  + .........  + .........  + .........  + .........  + .........  +  360 
CDR3  <Cl 
YYCAAWDDSLNGHVLFGGGTKLTVLGQPKA  116 
lalLl  TTATTACTGTGCAGCATGGGATGACAGCCTGAATGGTCATGTGCTATTCGGCGGAGGGACCAAACTGACCGTCCTGGGTCAGCCC~GGC  347 
361  .........  + .........  +  .........  +---  lalLIC3c  ....  + .........  + .........  +  .........  + .........  +  450 
Ji2  ---G  ...................  G ...........  A- 
Ci2  Val  ............. 
A  P  S  V  T  L  F  P  P  S  S  E  E  L  Q  A  N  K  A  T  L  137 
lalLl  TGCCCCC  TCGGTCACTCTGTTCCCGCCCTCCTC  TGAGGAGCTTCAAGCCAACAAGGCCACACT  410 
451  .........  +--  LC4s  .........  + .........  + .........  LCc  ---+---  513 
CI2  ............................................................... 
C13  ........................  A ...................................... 
Figure 2.  The nucleotide and amino acid sequences of the L1 L chain V region, designated HumlalL1 and abbreviated lal.L1. The expressed V gene 
was rearranged to Jk2 and CX2 genes (35, 36); their reported germline sequences are included for comparison. Also included is a relevant portion 
of the CX3 sequence, which differs from CX2 by only one nucleotide in the sequenced region. The complete nucleotide and amino acid sequences 
of lalL1 are given, while all other sequences  are given only at the positions where they differ from lalL1, in the overlapping regions. The replacement 
amino acid residue is given below the replacement nucleotide change. The bars denote the identities; the regions of four oligomers are underlined 
and their names are given underneath. The CDRs are marked. 
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hvlLl  ......  CACCCAC,  CAACCACATCTGTCCTCTAGAGAATCCCC  TGAGAGCTCCGT  TCCTCACCATGGACTGGACC  TGGAGGATCCTC  TTCTTGGTGGCAGCAGCCACAGGTAAGAGGC  TCC  -86 
.........  halLiUls  ........  + .........  +  .........  §  .........  + .........  +  .........  + .........  + .........  + .........  + .........  * 
halLl  GAGCAT  .................................................................................................................. 
V35  GAGCAT  .................................................................................................................. 
i-I  .............................................  - .......................................................................... 
20P3  .........  - ..................................................................................................  ￿9 ........... 
Wil2  ....................................................  - .......................................................  ￿9 ........... 
￿9 *IyA  H  S  Q  V  Q  L  V  Q  S  G  A  E  V  K  12 
hvlLl  CTAGTC  CCAG  TGATGAGAAAGA.  GATTGAGTCCAGTCCAGGGAGATCTCATCCACTTCTGTGTTCTCTCCACAGGAGCCCAC  TCCCAGGTGCAGC  TGGTGCAGTC  TGGGGCTGAGGTGAA  35 
.........  + .........  §  .........  + .........  §  .........  +  .........  + .........  +  .........  + .....  I---+  .........  + .........  +  .........  + 
halLl  ......................  ￿9  ................................................................................................. 
V35  ......................  G ................................................................................................. 
I-I  ......................  .  ................................................................................................. 
20P3  ..........................................................................  - ............................................. 
ML3  .....................................................................................  -  .................................. 
Wi 12  ..........................................................................  - ...........................  A ................. 
CDRI  CDR2 
K  T  Y  Y  H  Q  G  L  E  W  M  G  W  I  N  52  K  P  G  A  S  V  K  V  S  C  A  S  G  Y  F  T  G  M  W  V  R  Q  A  P  G 
hvlLl  GAAGCC  TGGGGCCTCAGTGAAGGTCTCCTGCAAGGCTTCTGGATACACCTTCACCGGCTAC  TATATGCACTGGGTGCGACAGGCCCCTGGACAAGGGCTTGAGTGGATG  GGATGGATC~  155 
hvILIR  ................................................................................................................  C ....... 
.........  +  .........  +  .........  +  ....  GIy--+  .........  +  .....  Ala-+-Gln  .....  +  .........  §  .........  +  .........  + .........  +--Arg  ....  + 
halLl  ..................  T ...........  T ....  G ....................  ~ .... ~-A ................................  A ....................... 
V35  ......................................................  (halLICls)  ..............................................  C ....... 
I-I  .....  T .......................................................................  N .......................................... 
20P3  ........................................................................................................................ 
ML3  ........................................................................................................................ 
Wil2  ...............................  G ..........................  C ............................................................. 
CDR2 
P  T  M  T  R  D  T  S  I  $  T  A  Y  E  L  S  L  R  S  D  D  T  A  92  N  S  G  G  T  N  Y  A  Q  K  F  Q  G  R  V  M  R 
hvlLl  CC CTAACAGTGGTGGCACAAAC  TATGCACAGAAGTTTCAGGGCAGGGTCACCATGACCAGGGACACGTCCATCAGCACAGCCTACATGGAGCT  GAGCAGGC  TGAGATC  TGACGACAC  GGC  275 
.........  + .........  GIy---GIy-+  .........  *  .........  +--Leu  ....  +  .........  + .........  +  ........  halLiF3e  ---Thr---+  .........  + 
halLl  ...................  GG .....  G .........................  C ...................................................  C ............... 
V35  .....................................................  GT ................................................................  T 
i-i  ........................................................................................................................ 
20P3  ........................................................................................................................ 
ML3  ........................................................................................................................ 
Wil2  ............................  G .........................  C ...................  A ............................................. 
V  Y  Y  C  A  R  *7-met*  **9-met** 
hvl L1  CG TGTATTAC  TGTGCGAGAGACACAG  TGTGA~CCCACAT~r 
.........  + ......  Ile+  .........  + .........  +  ......  V35DIc  ---+- 
halLl  ...............  C-TT  .......................................... 
V35  ............................................................. 
i-I  ............................................................. 
20P3  .................  CG .......................................... 
ML3  .............  A--.  ............................................ 
Wil2  ...................  . ......................................... 
336  Difference 
15/388 
5/496 
2/496 
2/388 
1/374 
6/388 
Figure 3.  The genomic structures of the HumhvlL1 and the HumhvlLIR genes (abbreviated hvlL1 and hvlL1R, respectively). Also included are 
the sequences of the halL1 rearranged Vh gene, the V35 and 1-1 germline Vh genes, the 20P3, the ML3, and the Wil2 Vh cDNAs (19, 21, 22, 37, 
79). The complete nucleotide and amino acid sequences of hvlL1 are given; all other sequences are given only at the positions where they differ from 
hvlL1 in the overlapping regions, except for hvlLIR, which includes only the relevant stretch. The replacement amino acid residues of halL1 and 
hvlLIR are given; the bars denote the identities, while the dots denote the unknown regions, the introns, or the deleted 3' flanking region. The 
differences between hvlL1 and each V gene are given at the end. The regions of five oligomers are underlined and their names are given,  The CDKs, 
the splice, and recombination signal sequences are marked. 
tic/to both V35 and 1-1, but differed from all other remaining 
Vhl genes. An oligomer complementary to this region was 
prepared  (designated V35Dlc;  marked  in Fig.  3),  and was 
used with halL1Uls to amplify spedficaUy the HalLl-related 
Vhl  germline  genes  from  the  ML  germline  DNA.  The 
amplified DNA was cloned into M13, and seven recombinant 
clones were chosen randomly for sequencing.  The results 
showed that  all had identical sequences,  except for a single 
base difference  at nudeotide position  148;  four clones had 
T  (similar to the halLl-rearranged gene and the  1-1 pseu- 
dogene), while the remaining three clones had C (similar to 
the V35 functional gene) (Fig.  3).  The data indicated that 
the gene represented by the first four clones was more likely 
to be the germline counterpart for halL1 and was thus desig- 
nated HumlvlL1. The Vh gene represented by the latter three 
clones was then designated HumlvlL1R,  the R  stands  for 
Arg  (instead  of Trp for lvlL1)  at amino acid position  50. 
As can be seen in Fig. 3, the hvlL1 sequence is identical 
to halL1 in the 5' flanking, leader, and intron regions, and 
differs from halL1 by 15 nucleotides in the coding regions. 
The data suggested strongly that hvlL1 encodes the halL1 
H chain. However, could we be sure that hvlL1 was indeed 
the germline gene for halL1 and that the differences between 
them were due to somatic changes?  Recently, van Es et al. 
(38)  addressed  this  issue by comparative PCR,  using  one 
primer corresponding to the putatively  germline sequence 
on one hand, while using a related primer corresponding to 
the putatively mutated sequence on the other hand.  Based 
on this strategy, two oligomers were prepared; hvlL1Cls and 
halL1Cls (marked in Fig. 3; C1 denotes the first CDR) cor- 
respond to the putative  germline hvlL1  sequence and  the 
potentially mutated halL1 sequence, respectively.  Each was 
paired with halL1F3c (marked in Fig. 3; F3 denotes the third 
FR) in PCR using genomic DNA from the L1 hybridoma 
or  the  PBL  of  donor  ML.  The  results  showed  that 
amplification of hybridoma DNA with both primers yielded 
a clear band of expected size; in contrast, only hvlLICls led 
to  a  successful  amplification  in  the  PBL  DNA  (data  not 
835  Olee et al. Table  1.  Summary of Somatic Changes in the L1  V Regions, Encoded by V, D, and J  Genes 
Regions  Mut  R  R/S  Conserved*  Nonconserved* 
H chain 
Vh  15  11  2.8 
CDR  6  6  >>>S 
FR  9  5  1.8 
Jh  1  0  0 
31,  G >  A  P >NP* 
33, Y>Q 
59, N>G 
61,  A >  G  NP >  P 
24,  A >  G  NP >  P 
70, M>L 
87,  R>T  +  >P 
98,  R  >  I  +  >  NP 
L chain 
V),  4  3  3 
CDR  2  2  >>>  26, S >  N 
31, S>G 
FR  2  1  1  86, 
J),  3  1  0.5  101, L >  V 
D>A  -  >NP 
The abbreviations used are: rout, mutations; R, replacement changes; R./S, the ratio of the replacement to the silent changes. 
* For each  conserved  replacement  change, the amino acid  position, the germline  residue, and the mutated  residue  are given; > stands for "changes  to". 
* For each nonconserved  change, additional  information  about the chemical  properties (i.e. +,  -, P, and NP denote + charged, -  charged,  polar, 
and nonpolar, respectively) of involved amino acid residues is given. For example, at position 31 of the H chain, the polar Gly residue changes to 
the nonpolar Ala residue. 
S >>>denotes infinity. 
shown), suggesting that there was not a germline Vh gene 
in ML that contained the hal_L1Cls sequence. Combined with 
the sequence  data of seven randomly picked clones,  these 
findings demonstrated that hvlL1 was the germline gene for 
halL1. 
Thus, the 15 nucleotides by which halL1 differs from hvlL1 
represent somatic mutations; they consisted of two double- 
base changes and 11  single-base  changes (Fig.  3 and Table 
1).  Of the 15 mutations, six were in the CDRs and nine 
in the FRs. Interestingly, all six (100%)  changes in CDRs 
were replacement changes, while only five of nine (56%) 
changes in the FR were replacement changes.  The replace- 
ment changes included both conserved and nonconserved 
changes of various natures (i.e., from polar to nonpolar or 
vice versa, positive charged to polar or nonpolar, etc.) (Table 1). 
Identification and Characterization of the Germline VA Gene 
for the L1 L  Chain.  This was done similarly to the iden- 
tification of the germline counterpart for the halL1 H chain. 
By priming with  lalL1U2s  and LalLIC3c,  the lalLl-re- 
arranged gene was amplified and characterized.  Comparison 
of the lalL1 sequence with both Genbank and EMBL data- 
bases revealed that it was equally similar to all three reported 
human germline VM  genes (i.e.,  Humlv117, VM.1,  and 
IGLV1S2) (27, 39, 40). The result prevented us from rational 
design of the appropriate downstream primers, and thus made 
the identification of the lalLl-corresponding germline V gene 
more difficult. To circumvent the problem, we prepared a 
series of downstream primers corresponding to the 3' end 
of the Vl~,gene coding region in the lalL1 sequence and to 
the immediate downstream region of the reported Humlv117 
germline gene sequence (27). Each of these primers was paired 
with lalL1U2s and was tried in the PCR amplification of 
the putative germline gene for lalL1; two primers led to the 
specific amplification of the desired  V~, gene. 
When lv117D1c (complementary to the conserved nonamer 
region of lv117; marked in Fig. 4) was used, characterization 
of the clear band in the amplified DNA revealed a new VM 
gene, designated HumlvlL1. Importantly, amplification with 
the lalL1C3cl primer (complementary to the 3' end of the 
lalLl-rearranged gene sequence,  marked in Fig.  4)  also re- 
vealed a sequence identical to lvlL1 in the overlapped region. 
Together, these data showed that the lvlL1 sequence repre- 
sented the authentic sequence  of a new VM gene, instead 
of a hybrid sequence  of various VM  genes. 
The lvlL1 gene is identical to the lalL1 gene in the 5' un- 
translated, the leader, and the intron regions, while it differs 
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lalLl 
M  A  S  F  P  L  L  L  T  L  L  T  H  C  A  -5 
.... CAGCTGTGGGTAGAGAAGACAGGAC  TCAGGACAATCTCCAGCATGGCCAGC  TTCCCTCTCCTCCTCACCC  TCCTCACTCACTGTGC  -129 
.......  lalLIU2s  ..........  + .........  + .........  +  .........  + .........  + .........  +  .........  +  90 
GCTT  ...................................................................................... 
ivlLl 
91 
lalLl 
G**  -4 
AGGTGACAGGATGGGGA•CAAGAAAGGGGcC•TGGGAAG••CATGGGGCCCTGCTTTCTCCTCTTGTCTCCTTTTGTCTCTTGTCAATcA  -39 
.........  +  .........  +  .........  +  .........  + .........  + .........  + .........  + .........  +  .........  +  180 
.......................................................................................... 
IvILI 
181 
lalLl 
**lyS  W  A  Q  S  V  L  T  Q  P  P  S  A  S  G  T  P  G  Q  R  V  18 
CCATGTCTGTGTCTCTCTC  AC  TTCC  AGGGTCCTGGGCCC  AGTC  TGTGCTGAC  TCAGCCACCC  TCAGCGTCTGGGACCCCCGGGCAGAGGG  52 
.........  + .........  + .........  + ........  I+  .........  +  .........  +  .........  + .........  + .........  +  270 
.......................................................  A .................................. 
friLl 
271 
lalLl 
ivlLl 
361 
lalLl 
CDRI 
T  I  S  C  S  G  S  S  S  N  I  G  S  N  T  V  N  W  Y  Q  Q  L  P  G  T  A  P  K  L  L  48 
TCACCATC  TC T TGTTC  TGGAAGCAGC  T CCAACATCGGAAGTAATACTGTAAAC  TGGTACCAGCAGCTCCCAGGAACGGCCCCCAAACTCC  142 
.........  + .........  +---Ash---+  ........  Gly ........  + .........  + .........  + .........  +  .........  +  360 
....  --  ...................  A .............  ~ ................................................... 
lalLiCls 
CDR2 
I  Y  S  N  N  Q  R  P  S  G  V  P  D  R  F  S  G  S  K  S  G  T  S  A  S  L  A  I  S  G  78 
TCATCTATAGTAATAATCAGCGGCCCTCAGGGGTCCCTGACCGATTCTCTGGCTCCAAGTCTGGCACCTCAGCCTCCCTGGCCATCAGTG  232 
.........  + .........  +  .........  + .........  + .........  + .........  + .........  + .........  +  .........  +  450 
.......................................................................................... 
ivlLl 
451 
lalLl 
CDR3 
L  Q  S  E  D  E  A  D  Y  Y  C  A  A  W  D  D  S  L  N  G  *7-mer*  98 
GGC TCCAGTC  TGAGGATGAGGC TGATTAT  TAC  TGTGCAGCATGGGATGACAGCCTGAATGGTCCCACAGTGCTCCAGGCCAATGGGGAAC  322 
.........  +  .........  +---Ala---+  .........  +--  lalLIC3cl  ....  + .........  + .........  + .........  +  540 
........................  C .....................................  . ........................... 
**9-mer** 
ivlLl  TGAGACAAGAACCCCCTTCTTC  344 
541  .......  ivll7Dlc  ---  562 
Figure 4.  The genomic structures of the HumlvlL1 gene (abbreviated  lvlL1). Also included is the lalLl-rearranged gene sequence. The complete 
nucleotide and amino acid sequences of hvlL1 are given, while the lalL1 sequence  is given only at the positions where it differs from lvlL1, in the 
overlapping regions. The replacement amino acid residues of lalL1 are given; the bars denote the identities, while the dots denote the unknown region 
in the 5' flank of lvlL1 or the deleted 3' flanking region of lalL1. The regions of five oligomers are underlined and their names are given. The CDILs, 
the splice, and recombination signal sequences are marked. 
from lalL1 by four nucleotides in the VX gene coding region 
(Fig.  4).  The  data suggested that  lvlL1 encodes the lalL1 
L chain. To verify this conclusion, the aforementioned com- 
parative  PCR  was  done.  Two  oligomers  were  prepared; 
lvlL1Cls and lalL1Cls  (marked in Fig.  4;  C1 denotes the 
first CDR) correspond to the putative germline lvlL1 sequence 
and the potentially mutated lalL1 sequence, respectively. Each 
was paired with lalL1C3cl  in PCR using genomic DNA 
from the L1 hybridoma or the PBL of donor ML. The results 
showed that  amplification  of hybridoma DNA with both 
primers yielded a clear band of expected size; in contrast, only 
lvlL1Cls led to a successful amplification in the PBL DNA 
(data not shown), suggesting that there was not a germline 
VM gene in ML that contained the lalLICls sequence. Com- 
bined with the sequence data of five randomly picked clones, 
these findings demonstrated that lvlL1 was the germline gene 
for lalL1,  and that  the four base differences in lalL1 repre- 
sented mutations. Of the four nucleotide changes, two were 
in the CDRs and two were in the FRs (Fig.  4).  Interest- 
ingly, both nucleotide changes in CDRs were replacement 
changes, while one-half of the changes in FP,  s were replace- 
ment  changes  (Table  1). 
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Molecular Characterization of  the 191 Vk and VIc cDNA.  To 
improve the efficiency of APCR, the 3' chain cDNA of the 
second hybridoma was amplified with one major modification, 
namely the tailed cDNA was first amplified with a new primer 
(GClc,  marked in Fig.  5),  downstream  of the initial  GCc 
primer used in the first hybridoma. The amplified DNA of 
the  expected size was  enriched  from  the  agarose  gel and 
reamplified  with  the  GCc  primer.  Similarly,  two  g  L 
chain-specific primers (i.e.,  KCc and KClc, marked in Fig. 
6) were designed and used to amplify the g chain V  gene 
cDNA. The amplified DNA was cloned into M13 and the 
recombinants were analyzed. The results showed that the D1 
IgG RF contained Vh3 and Vk3 genes, designated Humha3dl 
and Humka3dl,  respectively (Figs.  5 and 6). 
The CDR3 of ha3dl contained a stretch of 10 bp that was 
homologous to Dk4  (31)  and a nonoverlapping  stretch  of 
5 bp identical to D21/10 (30), suggesting that the ha3dl H 
chain CDR3 might be generated by a D-D fusion of these 
two Dh genes and with one mutation  (32) (Fig.  5).  Also, 
the ha3dl H  chain uses a Jh4 and a C3'3 gene (Fig.  5);  its 
Jh region  is identical  to a Jh4  sequence (33),  and its C3'3 
region is identical to the reported C3'3 sequence over a 77-bp ha3dl 
VH26 
ha3dl 
VH26 
ha3dl 
VH26 
E  V  Q  L  V  E  S  G  G  G  L  V  Q  P  G  G  S  L  R  L  S  C  A  A  S  G  F  T  F  S  30 
GAGGTGCAGC  TGGTGGAGTC  TGGGGGAGGCTTGGTACAGCCTGGGGGGTCCCTGAGACTCTCCTGTGCAGCCTCTGGATTCACCTTCAGT  90 
.........  +  .........  +  .........  +  .........  +  .........  +  .........  +  .........  +  .........  +  .........  + 
............  T .........................................................................  T--C 
CDRI  CDR2 
N  Y  S  M  N  W  V  R  Q  A  P  G  K  G  L  E  W  V  S  Y  I  S  S  S  S  S  T  I  Y  Y  60 
AAC TATAGCATGAACTGGGTCCGCCAGGC  TCCAGGGAAGGGGCTGGAGTGGGTTTCATACATTAGTAGTAGTAGTAGTACCATATACTAC  180 
.........  +  .........  +  .........  +  .........  +  .........  + .........  +  .........  +  .........  +  .........  + 
-G ....  GC .....  G .......................................  C---GCT  ......  G .....  G--G---G--C  ....... 
CDR2 
A  D  S  V  K  G  R  F  T  I  S  R  D  N  A  K  N  S  L  Y  L  Q  M  N  S  L  R  A  E  D  90 
GCAGAC  TC  TGTGAAGGGCCGATTCACCATCTCCAGAGACAATGCCAAGAACTCACTGTATCTGCAAATGAACAGCCTGAGAGCCGAGGAC  270 
.........  +  .........  +  .........  +  .........  +  .........  +  .........  +  .........  +  .........  +  .........  + 
........  C ...........  G .....................  T ........  A-G .................................... 
ha3dl 
VH26 
Dk4 
D21/10 
Jh4 
~3 
CDR3 
T  A  V  .Y  Y  C  A  R  S  G  Y  R  G  G  D  Y  W  G  Q  G  T  L  V  T  V  S  S  A  S  T 
ACGGCTGTG  TATTAC  TGTGCGAGAAGCGGATACAGAGGGGGCGACTACTGGGGCCAGGGAACCCTGGTCACCGTCTCCTCAGCTTCCACC 
.................................................................................  +  +  +  +  +  +  +  +  + 
..... C--A .............  A- 
-T  ........ 
120 
360 
K  G  P  S  v  F  P  L  A  P  C  S  R  S  T  S  G  G  T  A  A  L  G  C  L  V  K  D  Y  F  150 
ha3dl  AAGGG•••AT•GGT•TT••C••TGGCG•••TGCTCCAGGAGCACCTCTGGGGGCACAGCGGCCCTGGGCTGCCTGGTCAAGGACTACTTC  450 
................................................................... 
+  +  +  +  +  +  +  GCc  ........  + 
~3  ....................................................................................... 
ha3dl 
P  E  P  V  T  V  S  W  N  S  160 
CCCGAACCGGTGACGGTGTCGTGGAACTCA  480 
.........  +  .......  GCIc  .... + 
Figure 5.  The nucleotide and amino acid sequences of the D1 H  chain V region,  designated Humha3dl and abbreviated ha3dl. The nucleotide 
sequence in the Vh gene-encoded region was compared with all Vh gene sequences in the GenBank and EMBO databases, and the most homologous 
VH26 gene is given for comparison (45, 46). The expressed V gene was rearranged to Jh4 and "y3 genes (33, 41); their reported germline sequences 
are included for comparison.  The nucleotide sequence in the CDR3 of ha3dl was compared with all reported Dh gene sequences, and the 2 most 
homologous Dh gene segments were identified (30, 31); they are given for comparison. The complete nucleotide and amino acid sequences of ha3dl 
are given, while all other sequences are given only at the positions where they differ from ha3dl, in the overlapping regions. The bars denote the 
identities.  The regions of two oligomers are underlined and their names are given underneath. The CDRs are marked. 
region (41). On the other hand, the ka3dl L chain uses a 
Jkl gene (42) (Fig. 6); its Jk and Ck regions are identical 
to reported germline sequences (42,  43). 
Discussion 
In an effort to define the mechanisms for the generation 
of IgG RFs in RA patients, we cloned and sequenced the 
expressed Ig V  genes of the L1 and D1 IgG RF-secreting 
hybridomas, derived from the unmanipulated synovial B cells 
of two RA patients. Thereafter, we also identified and charac- 
terized the germline counterparts of the corresponding rear- 
ranged L1 H and L chain V genes. The results showed that 
the L1 H chain was generated from the HumhvlL1, the Jh3, 
and the C71 genes;  and that the L1 L chain was encoded 
by the HumlvlL1, theJh 2, and the CA 2 genes. In addition, 
the data suggest that the H chain CDR3 might derive either 
from the D21/9 gene only or from three separate Dh genes 
(i.e., Dn4, D22/12, and Dxp'l) (30, 31). The germline coun- 
terparts of the D1 H and L chain V genes are in the process 
of characterization.  However, a computer search for homol- 
ogous genes among 56,368  sequences in the GenBank and 
EMBO databases revealed that ka3dl differs from the Vg gene 
by only one base in the third CDK (44) (Fig. 6), while ha3dl 
is most similar to the VH26 gene (45,  46)  (Fig.  5). 
The hvlL1 germline Vh gene is almost identical to the 
20P3 Vh cDNA sequence, which is a part of the restricted 
fetal antibody repertoire (20);  20P3 differs from hvlL1 by 
only one double-base  at the WD junction, suggesting that 
the difference might be due to an imprecise joining of an 
hvlL1 gene to a rearranged DJ gene. In addition, hvlL1 is 
highly homologous to the V35 gene, located within 240 kb 
of the Jh locus. HvlL1 and V35 differ from each other by 
five nucleotides over a stretch of 496 bp; they are also very 
similar to the HumhvlL1K functional gene and the 1-1 pseu- 
dogene (Fig. 4). These four genes may represent either the 
allelic forms of a single Vh gene locus or different Vh genes 
residing at the separate gene loci.  Family studies with in- 
formative probes are required to resolve this issue. Of note, 
similar clusters of several highly homologous germline Vh 
genes have been observed  in a few cases (47-49). 
Previously, extensive studies in mice have shown that cer- 
tain Jh-proximal Vh genes are expressed preferentially during 
early ontogenic development, and that a few of such Vh genes 
frequently encode autoantibodies (50-53).  Similar findings 
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EIVLTQSPATLSLSPGERATLSCRASQSVS  30 
ka3dl  GAAATTGTGTTGACACAGTCTCCAGCCACCCTGTCTTTGTCTCCAGGGGAAAGA~CACCCTCTCcTGcAGGGCCAGTCAGAGTGTTAGC  90 
.................................................................................  +  +  +  +  +  +  +  +  + 
Us  .......................................................................................... 
......................................................................................  RF-TMCI  C  T  A  A 
CDRI  CDR2 
SYLAWYQQKPGQAPRLLIYDASNRATGIPA  60 
ka3dl  AGCTACTTAGCCTGGTACC~CAGAAACCTGGCCAGGCTCCCAGGCTCCTCATCTATGATGCATCC~CAGGGCCACTGGCATCCCAGCC  180 
.........  + .........  + .........  + .........  + .........  + .........  + .........  + .........  + .........  + 
Us  .......................................................................................... 
RF-TMCI  --GC  ................................................................  A ..............  T--G--- 
CDR3 
RFSGSGSGTDFTLTISSLEPEDFAVYYCQQ  90 
ka3dl  AGGTTCAGTGGCAGTGGGTCTGGGACAGACTTCACTCTCACCATCAGCAGCCTAGAGCCTG~GATTTTGCAGTTTATTACTGTCAGCAG  270 
.........  + .........  t .........  + .........  + .........  + .........  + .........  + .........  + .........  + 
Vg  .......................................................................................... 
RF-TMCI  ..................................  G .....  T-G ............................  C .................  C 
CDR3 
R  S  N  W  P  W  T  F  G  Q  G  T  K  V  E  I  K  R  T  V  A  A  P  S  V  F  I  F  P  P 
ka3dl  CGTAGCAAC  TGGCCGTGGACGT  TCGGCCAAGGGACC  AAGGTGGAAATCAAACGAACTGTGGCTGCACCATCTGTC  T TCATC  TTCCCGCCA 
.........  + .........  + .........  + .........  + .........  + .........  + .........  +  KCc  --+ ....  KCIc 
Vg  ..............  T 
RF-TMCI  ....  A---T  .....  T 
Jkl  ..................................... 
Ck  ................................ 
120 
360 
ka3dl 
S  D  122 
TCTGATG  367 
KCIc  - 
Figure 6.  The nudeotide  and amino acid  sequences  of the D1 L chain  V region,  designated  Humka3dl  and abbreviated  ka3dl. The nucleotide  sequence 
of the most homologous  Vg gene is given for comparison (44). Also included  is the reported Vk sequence  of a IgM RF from a normal individual 
(61). The expressed  V gene  was rearranged  toJkl and Ck genes (42, 43); their reported germline  sequences  are included  for comparison. The complete 
nucleotide and amino acid sequences  of ka3dl are given, while all other sequences  are given only at the positions where they differ  from ka3dl, in 
the overlapping  regions. The bars denote  the identities; the regions  of two oligomers  are marked  and their  names  are given  underneath.  The CDRs are marked. 
have been noted in humans (15,  20,  33,  54).  For example, 
the most Jh-proximal Vh6 gene is expressed frequently during 
early ontogenic development and is used by polyspecific IgM 
autoantibodies (20, 22, 37, 54, 55). On the other hand, struc- 
tural analyses of many natural IgM autoantibodies from normal 
subjects have revealed that they use a restricted set of Ig V 
genes (12,  15,  33);  and several of these V  genes,  such as 
Humhv1051/51Pl  and VH26/30P1  genes, have been found 
to be expressed preferentially during early ontogenic devel- 
opment (19,  20,  22,  56,  57). 
The notable overlaps of the early antibody repertoire and 
the natural antibody repertoire, together with other obser- 
vations, have led to the "network" hypothesis (58).  It con- 
tends that natural autoantibodies play an important role in 
the ontogenic development and the subsequent homeostasis 
of a normal B cell repertoire. As such, some autoreactive V 
genes may be evolutionarily selected for preferential expres- 
sion, possible through their their proximity to the Jh locus 
and/or unique c/s regulatory elements (50,  51,  59,  60).  In 
the context of these data, the use of hvlL1 by the L1 self- 
associating IgG RF would suggest that L1 probably derived 
from a physiological natural autoantibody (with or without 
RF activity), but escaped from the normal mechanisms of 
regulation, possibility during a serious infection and/or tran- 
sient dysfunction of the immune system of the host, and thus 
became a monospecific, high affinity (with Kd at 10 -7 M) 
RF due to selection by IgG alone or IgG antibody-antigen 
complexes. In support of this conclusion is the recent report 
of the Vh gene sequence of the ML3 IgM RF, derived from 
the CD5 + B cells of a 19-wbold fetal spleen (22); the ML3 
differs  from hvlL1 by only one base over a stretch of 374 
bp (Fig. 3). Similarly, the ka3dl-corresponding germline Vg 
gene is expressed in fetal liver and apparently encodes the 
L chain of a IgM RF (i.e., TMC1) from a normal individual 
(56, 61). Moreover, the current conclusion is consistent with 
extensive studies of monospecific and high affinity IgM RFs 
from the peripheral blood of RA patients; they were found 
to use certain selected Ig V genes, similar to those used by 
the natural autoantibodies and the fetal antibody repertoire. 
For example, RF SJ2 used the most frequently expressed Vh 
gene in fetal liver (i.e., Humhv3005f3/GbSJ2/M72 or its ho- 
mologous 56Pl) (20, 49, 62); RFs TS1 and YES8c from two 
unrelated RA patients used Humhv1051/51Pl,  which also 
encodes the H chains of about 40% IgM RFs from unrdated 
patients with mixed cryoglobulinemia (14,  15, 62-64);  RF 
KL1  used  VH26/30P1;  RFs  TS1,  SJ3,  and  YES8c  used 
Humkv325/A27; RF TS2 used Humkv328h5; and RFs SJ1 
and SJ2 used Humlv117 (27, 45, 46, 61-63,  65-68).  How- 
ever, it should be noted that RF production in RA patients 
may be induced by different mechanisms, and thus the afore- 
839  Olee et al. mentioned hypothesis may not account for KF secretion in 
all RA patients. 
In addition to documenting the V gene origin of an IgG 
KF, the current data also provide evidence for the role of an- 
tigen selection in IgG RF production. Generally, during an 
antigen-driven response, B cells expressing mutated antibodies 
with higher affinity for the antigen are progressively selected. 
Frequently,  such affinity maturation is associated with the 
switch from IgM to IgG (69-75). These principles apply not 
only to antibody responses  to foreign antigens, but also to 
self-antigens.  For example, extensive studies of RFs and anti- 
DNA antibodies in normal and autoimmune mice showed 
that most IgG KFs from MRL/Ipr autoimmune mice had 
an average of 4.4 somatic mutations per V region, with the 
most mutated V region having seven mutations; in contrast, 
most IgM RFs (generated by polyclonal B cell activation) 
had an average of only 0.5 mutation per V region, with the 
most mutated V region having only two mutations (76, 77). 
Furthermore,  the former mutations occurred nonrandomly; 
they were located  much more frequently in CDR.s than in 
FKs, and often led to amino acid substitutions, resulting in 
an ratio of replacement (K) to silent (S) mutations >2.9 (76). 
Similar findings were obtained from analyses of IgG anti-DNA 
antibodies from MRL/lpr mice (78). 
As summarized in Table 1, the L1 KF had 16 and 7 muta- 
tions in its H and L chain V regions, respectively. Moreover, 
all eight changes in the CDRs of  both V genes caused amino 
acid substitutions, resulting in an R/S ratio of infinity (i.e., 
8/0).  In contrast, only 6 of 11 changes in the FKs of both 
V genes led to amino acid replacements, resulting in a R/S 
ratio of 1.2. Taken together with the high binding affinity 
of L1 toward the Fc fragment, these data suggest strongly 
that L1 RF was selected by the Fc fragment, and thus pro- 
vide the first direct evidence for an Fc-driven immune response 
in RA synovium. As for the D1 RF, although its L chain 
is nearly identical to the reported germline Vg gene, its H 
chain differs significantly  from the most closely related VH26 
gene, and includes many replacement changes in the first and 
second CDRs. Considering the high binding affinity of D1 
toward the Fc fragment, it is likely that the D1 IgG RF also 
derived from an Fc-driven response. 
The sequence data are available  from the EMBL/GenBank/DDBJ Data Libraries under the following ac- 
cession  numbers: X59702 (humighalll),  X59703 (humigha3dl),  X59704 (humighvlll),  X59705 
(humigka3dl), X59706 (humiglalll),  and X59707 (humiglvlll). 
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